| 产品详情 |
| Edit |   |
| Product Name | NAD Nucleotidase, Recombinant, Haemophilus influenzae (NadN, NAD Pyrophosphatase/ 5'-nucleotidase) |
| Description | Purity ~98% (SDS-PAGE). NadN (NAD nucleotidase) is a periplasmic enzyme from Haemophilus influenzae, a major pathogen of the respiratory tract in humans that has developed the capability to exploit host NAD(P) for its nicotinamide dinucleotide requirement. NadN plays a central role by degrading NAD into adenosine and NR (nicotinamide riboside), NMN to nicotinamide riboside and AMP to adenosine. It shows a broad substrate specificity, recognizing either mono- or di-nucleotide nicotinamides and different adenosine phosphates with a maximal activity on 5'-adenosine monophosphate. It can be used as an economically alternative to produce NR (nicotinamide riboside). Catalytic activity: NAD=AMP + NMNe+NR+PPi AMPe+Pi NMN=NR+Pi. Source: Recombinant protein corresponding to full-length Haemophilus influenzae NAD Nucleotidase, without the signal peptide corresponding to the first 26aa, expressed in E. coli. Molecular Weight: ~63kD Biological Activity: With AMP: 856.4nmol of Ade/min/mg of protei |
| Size | 50ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | 207287 |
| Price | |
| Order / More Info | NAD Nucleotidase, Recombinant, Haemophilus influenzae (NadN, NAD Pyrophosphatase/ 5'-nucleotidase) from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|